• Tatva Chintan Pharma Chem board meeting scheduled for 16 May 2026 to approve FY26 financial results.
• Board to consider recommending final dividend for FY26 subject to shareholder approval at AGM.
• Trading window closed from 1 April 2026 until 48 hours after results publication.